Navigation Links
New Analysis of Data Presented at AHA Regarding Effect of Effient® (Prasugrel) on Cardiovascular Events in STEMI Patients According to Timing of PCI
Date:11/16/2011

t outcomes and reduce the cost burden of ACS.(5)

Important Safety Information

What is the most important information patients should know about Effient?

Effient® (prasugrel) can cause bleeding. If patients have unexplained or excessive bleeding while on Effient, they should contact their doctor right away as some bleeding can be serious, and sometimes fatal. Patients should not take Effient if they currently have abnormal bleeding, such as stomach or intestinal bleeding, bleeding in their head, or have a history of stroke, or “mini-stroke” (also known as transient ischemic attack or TIA).


Patients should get medical help right away if they suddenly have slurring of speech, weakness or numbness in one part of their body, blurry vision, and/or severe headache. These may be symptoms of a stroke or TIA. If patients have a stroke or TIA while taking Effient, their doctor will probably stop Effient.  


Before having any surgery, patients should talk to their doctor about stopping Effient. If possible, patients should stop taking Effient at least 1 week (7 days) before any surgery, as instructed by their doctor who prescribed Effient.


Patients may also have a higher risk of bleeding if they take Effient and they: a) are age 75 or older, b) weigh less than 132 pounds, c) are taking anticoagulants (eg, warfarin) or regular daily use of NSAIDs, d) have had recent trauma, such as an accident or surgery, e) have severe liver problems, or f) have a stomach ulcer.


Patients should not stop taking Effient without talking to the doctor who prescribes it for them. People who are treated with angioplasty and have a stent, and stop taking Effient too soon, have a higher risk of a blood clot in the stent, having a heart attack, or dying.



What should patients tell their doctor before taki
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Triple Analysis: Leukemia, Cancer Vaccines and Peptides
2. Triple Analysis: Prostate Cancer, Angiogenesis and Peptides
3. PRA Early Phase Experts to Speak at Bioanalysis Conference
4. Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
5. New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response
6. Turkey Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2017
7. ReportsnReports - Hyper Acute Pancreas (Pancreatic Cancer) - Analysis and Forecasts to 2020
8. Molecular Devices, LLC Introduces SoftMax Pro® 6 Microplate Data Acquisition and Analysis Software With Powerful New Data Analysis and Reporting Features
9. Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011
10. DIFICID™ Demonstrated Early Superiority in the First 12 Days Compared to Vancomycin in New Analysis of Phase 3 Study Results
11. Afinitor (Breast Cancer) - Analysis and Forecasts to 2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... CHENGDU, China , Dec. 23, 2014 /PRNewswire/ ... a pharmaceutical company that specializes in patented biopharmaceutical, ... active pharmaceutical ingredients (API) today announced that the ... for its Good Manufacturing Practice (GMP) certificate of ... & Drug Administration,s (CFDA). The public notice period ...
(Date:12/22/2014)... , Dec. 22, 2014 NxStage ... manufacturer of innovative dialysis products, announced today that ... cleared its System One™ to perform hemodialysis overnight ... as home nocturnal hemodialysis. NxStage,s® System One is ... the FDA for this indication. ...
(Date:12/22/2014)... Dec. 22, 2014  ConvaTec, a privately-held medical products ... been appointed Interim Chief Executive Officer of the company, ... Ken Berger .  "The Board of Directors of ... ConvaTec over the past three years," said Magnus ... "We are confident that the company is well positioned ...
Breaking Medicine Technology:TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2
... FRISCO, Texas, Oct. 21 Assured Pharmacy (Pink Sheets: ... medications to more than 3,000 sufferers of chronic pain, announced ... month of September 2010 were $1,391,331 which equates to $66,253 ... when compared with total sales of $1,226,245 for September 2009 ...
... announces that a new market research report is available in ... 2010 http://www.reportlinker.com/p0316666/Japanese-Market-for-Urological-Devices-2010.html By ... nearly triple in value. This report analyzes the markets for ... - Prostate cancer - Urinary incontinence ...
Cached Medicine Technology:Assured Pharmacy Reports Same Store Sales for the Month of September 2010 2Reportlinker Adds Japanese Market for Urological Devices 2010 2Reportlinker Adds Japanese Market for Urological Devices 2010 3Reportlinker Adds Japanese Market for Urological Devices 2010 4Reportlinker Adds Japanese Market for Urological Devices 2010 5Reportlinker Adds Japanese Market for Urological Devices 2010 6Reportlinker Adds Japanese Market for Urological Devices 2010 7Reportlinker Adds Japanese Market for Urological Devices 2010 8Reportlinker Adds Japanese Market for Urological Devices 2010 9Reportlinker Adds Japanese Market for Urological Devices 2010 10Reportlinker Adds Japanese Market for Urological Devices 2010 11Reportlinker Adds Japanese Market for Urological Devices 2010 12Reportlinker Adds Japanese Market for Urological Devices 2010 13Reportlinker Adds Japanese Market for Urological Devices 2010 14Reportlinker Adds Japanese Market for Urological Devices 2010 15Reportlinker Adds Japanese Market for Urological Devices 2010 16
(Date:12/26/2014)... DW-InductionHeating.com (DaWei Induction Heating Co.) is a comprehensive high-tech ... marketing of a series of induction heating equipment. Today, ... of induction brazing equipments . , According to ... refers to the joining of two or more ... manager says that there are fundamental differences in the ...
(Date:12/25/2014)... December 26, 2014 The microscopy ... of 7.2% to reach $5,756.0 million by 2019. ... microscopy market. The electron microscopes product segment is ... forecast period. , Rising focus on nanotechnology, technological ... of the microscopy market. , Get Full Copy ...
(Date:12/25/2014)... The click strand woven ... and durability. Today, the business announces a click ... until Jan. 30, 2015. , Click strand woven ... BambooFlooringChina.com is a well-known brand in the bamboo ... find a reliable bamboo flooring supplier. , “We ...
(Date:12/25/2014)... The report “TS-1 (Colorectal Cancer) – ... current treatment landscape, unmet needs, current pipeline and commercial ... anti-cancer drug which is typically used for treating colorectal ... for treating gastric cancer and pancreatic cancer. TS-1 is ... was first approved in 1999 in Japan for the ...
(Date:12/25/2014)... December 26, 2014 “Every three months the ... changes. A-line sweetheart evening dress will be one of the ... manager of Yunx.co.uk says. Today, the company releases 26 A-line ... up to 80% off. , “We are trying our ... style with our latest designs. Along with affordable prices, we ...
Breaking Medicine News(10 mins):Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3
... China, May 6 /Xinhua-PRNewswire/ -- WuXi PharmaTech ... pharmaceutical, biotechnology and medical device,research and development ... United States, announced today that it has ... (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ), ,In ...
... Congo Red commonly used in silk clothing manufacture ... environmentally benign way. , Congo Red is an ... and is a suspected carcinogen and mutagen. To ... disodium salt of 3,3,-(1E,1,E)-biphenyl-4,4,-diylbis(diazene-2,1-diyl)bis(4-aminonaphthalene-1-sulfonate). It is a benzidine-based ...
... called naringenin silences infection pathway, hints of new disease ... grapefruit flavonoid naringenin inhibits the secretion of Hepatitis C ... new approach for treating the disease, according to a ... the global population is infected with HCV, which can ...
... CNS Response, Inc.,(OTC Bulletin Board: CNSO) ... Medical Officer, Walden Behavioral Care Inpatient Psychiatry ... session at the American,Psychiatric Association (APA) 161st ... Medication Predictions in,Treatment Refractory Eating Disorder Patients," ...
... Product Introduction and ... Best Interactive Consumer Campaign, WEST CONSHOHOCKEN, Pa., May ... the healthcare,industry, announced today it received two silver awards at ... May 1, 2008. Cadient Group campaigns were honored in the,categories ...
... million on ... per share, - Adjusted net income increased 100 percent to $44 million, or $0.47 per ... ... of $1.55 to $1.60 per share, with a tax rate in a range of 23% to ...
Cached Medicine News:Health News:WuXi PharmaTech Announces Postponement of Proposed Follow-on Offering 2Health News:Sounding out Congo Red 2Health News:Grapefruit Compound Inhibits Hepatitis C Virus 2Health News:CNS Response, Inc.: Poster Session on Referenced-EEG Guided Medication to Be Presented at the American Psychiatric Association 161st Annual Meeting 2Health News:Cadient Group Continues Winning Streak; Receives Multiple Honors at 2008 Pharmaceutical Advertising and Marketing Excellence Awards 2Health News:Perrigo Reports Record Sales and Earnings for Third Quarter Fiscal 2008 2Health News:Perrigo Reports Record Sales and Earnings for Third Quarter Fiscal 2008 3Health News:Perrigo Reports Record Sales and Earnings for Third Quarter Fiscal 2008 4Health News:Perrigo Reports Record Sales and Earnings for Third Quarter Fiscal 2008 5Health News:Perrigo Reports Record Sales and Earnings for Third Quarter Fiscal 2008 6Health News:Perrigo Reports Record Sales and Earnings for Third Quarter Fiscal 2008 7Health News:Perrigo Reports Record Sales and Earnings for Third Quarter Fiscal 2008 8Health News:Perrigo Reports Record Sales and Earnings for Third Quarter Fiscal 2008 9Health News:Perrigo Reports Record Sales and Earnings for Third Quarter Fiscal 2008 10Health News:Perrigo Reports Record Sales and Earnings for Third Quarter Fiscal 2008 11Health News:Perrigo Reports Record Sales and Earnings for Third Quarter Fiscal 2008 12Health News:Perrigo Reports Record Sales and Earnings for Third Quarter Fiscal 2008 13Health News:Perrigo Reports Record Sales and Earnings for Third Quarter Fiscal 2008 14Health News:Perrigo Reports Record Sales and Earnings for Third Quarter Fiscal 2008 15Health News:Perrigo Reports Record Sales and Earnings for Third Quarter Fiscal 2008 16
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Kaye Skin Hook, Single Prong...
Large....
These products are supplied non-sterile and must be sterilized before use. For insertion through the smokevac and nezhat-dorsey trumpet valve in conjunction with the universal instrument insert adapt...
Medicine Products: